Search

Ipamorelin is a synthetic pentapeptide and selective growth hormone secretagogue that mimics ghrelin at the GHS-R1a receptor to stimulate pulsatile growth hormone release. It is not FDA-approved and has not been evaluated in published human efficacy randomized controlled trials; the evidence base is preclinical. It is studied for relatively selective GH release with minimal effect on cortisol or prolactin.